These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17018389)

  • 1. Human cell engraftment after busulfan or irradiation conditioning of NOD/SCID mice.
    Robert-Richard E; Ged C; Ortet J; Santarelli X; Lamrissi-Garcia I; de Verneuil H; Mazurier F
    Haematologica; 2006 Oct; 91(10):1384. PubMed ID: 17018389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice.
    Yoder MC; Cumming JG; Hiatt K; Mukherjee P; Williams DA
    Biol Blood Marrow Transplant; 1996 May; 2(2):59-67. PubMed ID: 9118300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.
    Levac K; Menendez P; Bhatia M
    Exp Hematol; 2005 Nov; 33(11):1417-26. PubMed ID: 16263425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.
    Sadeghi B; Jansson M; Hassan Z; Mints M; Hägglund H; Abedi-Valugerdi M; Hassan M
    Bone Marrow Transplant; 2008 May; 41(10):895-904. PubMed ID: 18223695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
    Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GVHD after chemotherapy conditioning in allogeneic transplanted mice.
    Sadeghi B; Aghdami N; Hassan Z; Forouzanfar M; Rozell B; Abedi-Valugerdi M; Hassan M
    Bone Marrow Transplant; 2008 Dec; 42(12):807-18. PubMed ID: 18820712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage to incisors after nonmyeloablative total body irradiation may complicate NOD/SCID models of hemopoietic stem cell transplantation.
    Larsen SR; Kingham JA; Hayward MD; Rasko JE
    Comp Med; 2006 Jun; 56(3):209-14. PubMed ID: 16774130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
    Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
    Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
    Schmidt-Hieber M; Blau IW; Trenschel R; Andreesen R; Stuhler G; Einsele H; Kanz L; Keilholz U; Marinets O; Beelen DW; Fauser AA; Volin L; Ruutu T; Uharek L; Fietz T; Knauf W; Hopfenmüller W; Thiel E; Freund M; Casper J
    Bone Marrow Transplant; 2007 Apr; 39(7):389-96. PubMed ID: 17310135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation.
    Garcia-Perez L; van Roon L; Schilham MW; Lankester AC; Pike-Overzet K; Staal FJT
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
    Wulf-Goldenberg A; Eckert K; Fichtner I
    Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
    Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful allogeneic stem cell transplant for leukocyte adhesion deficiency using an adjusted busulfan-containing regimen.
    Yoshimoto A; Hashii Y; Kashiwagi H; Koizumi M; Tokimasa S; Fujisaki H; Ohta H; Hanai N; Ozono K; Hara J
    Pediatr Transplant; 2007 Jun; 11(4):453-5. PubMed ID: 17493230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
    Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
    Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.